Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County

Pharmacogenetics

Volumn 6, Issue 2, 1996, Pages 151-158

  London, Stephanie J ^a,c   Daly, Ann K ^b   Cooper, Jane ^b   Carpenter, Catherine L ^a   Navidi, William C ^a   Ding, Li ^a   Idle, Jeffrey R ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

CYP2E1; epidemiology; lung carcinoma; susceptibility

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASBESTOS; ASCORBIC ACID; BETA CAROTENE; CARCINOGEN; CYTOCHROME P450 ISOENZYME; DNA; RESTRICTION ENDONUCLEASE; TOBACCO SMOKE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DETOXIFICATION; DIETARY INTAKE; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC ACTIVATION; OCCUPATIONAL EXPOSURE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RACE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOS ANGELES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NITROSAMINES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING;

EID: 0029879495     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199604000-00002     Document Type: Article

References (33)

1. Cicioni C, London SJ, Garabrant DH, Bernstein L, Phillips K, Peters JM. Occupational asbestos exposure and mesothelioma risk in Los Angeles County: application of an occupation hazard survey job-exposures matrix. Am J Indust Med 1991: 20, 371-379.
2. Fowler FJ. Survey research methods. Beverly Hills CA: Sage Publications, 1988: 45-60.
3. Giovino GA, Schooley MW, Zhu B, Chrismon JH, Tomar SI, Peddicord JP, Merritt Rk, Husten CG, Eriksen MP. Surveillance for selected tobacco-use behaviors - united States, 1900-1994. MMWR 1994: 43, 1-43.
4. Gonzalez FJ, Idle JR. Pharmacogenetic phenotype and genotyping: Present status and future potential. Clin Pharmacokinet 1994: 26, 59-70.
5. Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa E, Iwase T, Tanaka M, Takahashi T, Watanabe S, Kino I, Tsugane S. The heme-binding region polymorphism of Cytochrome P450IA1 (CYP1A1), rather than the Rsa I polymorphism of IIE1 (CYPIIE1) is associated with lung cancer in Rio De Janeiro. Cancer Epidemiol Biomarkers Prevent 1995: 4, 63-67.
6. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991: 110, 559-565.
7. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little Brown, 1987: 137-141.
8. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H. The human CYP2E1 gene and lung cancer: Dra I and Rsa I restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 1995: 14, 85-88.
9. International Agency for Research on Cancer. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking (volume 38). Lyon, France: World Health Organization, 1986.
10. Iwahashi K, Nakamura K, Suwaki H, Matsuo Y, Ichiwaka Y. Relationship between genetic polymorphism of CYP2E1, ALDH2 and possible susceptibility to alcoholism. Alcohol and Alcoholism 1994: 29, 659-642.
11. Kato S, Shields PG, Caporaso NE, Hoover RN. Trump BF, Haruhiko S, Weston A, Harris CC. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992: 52, 6712-6715.
12. Kato S, Shields PG, Caparaso NE, Sugimura H, Trivers GE, Tucker M, Trump BF, Weston A, Harris CC. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prevent 1994: 3, 515-518.
13. Kelsell DP, Wolf CR, Spurr NK. An XmnI RFLP detected with a probe for the CYP2E gene locus on chromosome 10. Nucleic Acids Res 1990: 18, 3111.
14. Kim RB, O'Shea D, Wilkinson GR. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 1995: 57, 645-655.
15. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995: 87, 1246-1253.
16. McBride OW, Umeno M, Gelboin HV, Gonzalez FJ. A Taq I polymorphism in the human P45IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Res 1987: 15, 10071.
17. Okada T, Kawashima K, Fukushi S, Minakuchi T, Nishimura S. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics 1994: 4, 333-340.
18. Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, Gonzalez FJ. Chlorzoxazone is metabolized by human CYP1A2 as well as human CYP2E1. Pharmacogenetics 1995: 5, 143-150.
19. Orlowski E, Pohlaben H, Berrino F, Ahrens W, Bolm-Audorff U, Grossgarten K, Iwatsubo Y, Jocket KH, Brochard P. Retrospective assessment of asbestos exposure - II. At the job level: complementarity of job-specific questionnaire and job exposure. Int J Epidemiol 1993: 22 (Suppl 2):S96-S105.
20. Persson I, Johansson I, Bergung H, Dahl ML, Seidegard J, Rylander R, Rannus A, Hogberg J, Ingelman-Sundberg M. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 1993: 319, 207-211.
21. Peter R, Bocker R, Braune PH, Iwasaki M, Guengerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 1990: 3, 566-573.
22. Rogers RG, Crank J. Ethnic differences in smoking patterns: findings from the NHIS. Public Health Reports 1988: 103, 387-393.
23. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M. Association between restriction fragment polymorphism of the human P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991a: 82, 254-256.
24. Uematsu F, Kikuchi H, Abe T, Motomiya M, Ohmachi T, Sagami I, Watanabe M. Msp I polymorphism of the human CYP2E gene. Nucleic Acids Res 1991b: 19, 5797.
25. Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Tatsuya A, Satoh K, Motomiya M, Watanabe M. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 1994: 4, 58-63.
26. Ueno T, Gonzalez FJ. Transcriptional control of the rat hepatic CYP2E1 gene. Mol Cell Biol 1990: 10, 4495-4505.
27. US Department of Health and Human Services. Cancer among blacks and other minorities. Bethesda MD: National Cancer Institute. NIH Publication No. 86-2785, 1986.
28. US Department of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General. Bethesda, MD, Department of Health and Human Services. DHHS Publication No. CDC 90-8416, 1990.
29. Watanabe J, Yang J-P, Eguchi H, Hayashi S, Imai K, Nakachi K, Kawajiri K. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res 1995: 86, 245-248.
30. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988: 127, 188-199.
31. Willett WC. Nutritional epidemiology. New York: Oxford University Press, 1990: 245-269.
32. Villard PH, Seree E, Lacarelle B, Therene-Fenoglio MC, Barra Y, Attolini L, Bruguerole B, Durand A, Catalin J. Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung. Biochem Biophy Res Comm 1994: 202, 1731-1737.
33. Yang CS, Tu YY, Koop DR, Coon MJ. Metabolism of nitrosamines by purified rabbit liver microsomal P-450 isozymes. Cancer Res 1985: 45, 1140-1145.